Do you see the wood from the trees in EU4+UK market access systems, payers and decision-making processes?
Test your knowledge with these 5 single-choice questions developed by Dr. Nick Proctor, faculty member of Understanding Pharma Market Access & Payers in Europe.
A. About 10%
B. About 20%
C. About 30%
C. About 30%
A. Budget optimisation
B. Comparative clinical effectiveness
C. Cost effectiveness
D. All of the above
D. All of the above
A. France
B. Germany
C. United Kingdom
D. All of the above
D. All of the above
A. A robot for treating patients
B. A registry-based managed access programme for high cost drugs
C. A hospital drama series
B. A registry-based managed access programme for high cost drugs
A. The measure of added medical benefit (amélioration du service médical rendu) in France
B. Autonomous Sensory Meridian Response
C. Adding Sales Means Rebates
A. The measure of added medical benefit (amélioration du service médical rendu) in France